Dr. Bardia Nourbakhsh, MD

Dr. Nourbakhsh practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Nourbakhsh's NPI, 1760709976, was assigned on April 27, 2010. Dr. Nourbakhsh holds California license 127912.

Dr. Nourbakhsh's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Nourbakhsh's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Nourbakhsh is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Nourbakhsh to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nourbakhsh practices. Vendor and product names are available with a free account.

Neurology is Dr. Nourbakhsh's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Nourbakhsh is licensed in California.

CMS data shows 70 Medicare services from Dr. Nourbakhsh across 2 procedure codes in 2024, for 58 Medicare patients. Medicare paid $7,051 for them.

CMS counts 58 Medicare patients who saw Dr. Nourbakhsh in 2024. The largest group is under 65, with 29 patients. 60% of them have high blood pressure, and 57% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nourbakhsh's median patient age at 54, with 63% women.

In 2024, Dr. Nourbakhsh wrote 1,944 Medicare Part D claims for 77 patients. 89% of them were for generic drugs. CMS names the drug for 1,776 of them, across 47 drugs with 11 or more claims each, at $769,786 in total drug cost. In 2023, CMS named 1,915 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Nourbakhsh for performance year 2024, reported as part of a group. CMS lists Dr. Nourbakhsh as offering telehealth.

Dmand AI links 55 papers to Dr. Nourbakhsh, published from 2010 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Multiple Sclerosis, Fatigue and Multiple Sclerosis, Relapsing-Remitting. Dr. Nourbakhsh has published most often in Mult Scler. Dr. Nourbakhsh's most frequent co-authors are Emmanuelle L. Waubant, MD, Jennifer S. Graves, MD and Ellen Mahar Mowry, MD.

CMS Open Payments shows 19 general payments to Dr. Nourbakhsh from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Jazz Pharmaceuticals Inc. paid the most, $9,000. It also lists 2 research payments totaling $1,611 in 2024.